Skip to main content

Table 1 Baseline patient and treatment characteristics

From: Mapping patterns of para-aortic lymph node recurrence in cervical cancer: a retrospective cohort analysis

Variables  
Age (median, range) 47 years (24–75)
Stage  
IB 4 (11.4%)
IIA 1 (2.9%)
IIB 26 (74.2%)
IIIB 3 (8.6%)
IVA 1 (2.9%)
Pathology  
Squamous cell carcinoma 28 (80%)
Adenocarcinoma 2 (5.7%)
Adenosquamous 5 (14.3%)
HPV infection  
Positive 16 (45.7%)
Negative 8 (22.9%)
No data 11 (31.4%)
Primary tumor size (median, range) 4.7 (1.4–11)
 < 4 cm 11 (31.4%)
 ≥ 4 cm 24 (68.6%)
Initial lymph node involvement  
Pelvic 21 (60.0%)
Paraaortic 10 (28.6%)
Negative 8 (22.9%)
Initial treatment  
Definitive surgery alone 4 (11.4%)
Definitive CCRT 25 (71.4%)
Surgery + PORT 6 (17.2%)
PALN irradiation for initial treatment 10 (28.6%)
Time to PALN recurrence (median, range) 10.0 months (2.0–50.9)
Patterns of PALN recurrence  
Isolated PALN recurrence 14 (40%)
Concurrent local recurrence 8 (22.9%)
Concurrent distant metastasis 13 (37.1%)
No. of PALN per patient (median, range) 2 (1–12)
  1. HPV, human papilloma virus; CCRT, concurrent chemoradiotherapy; PORT, postoperative radiotherapy